Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam–avibactam  A. Chauzy, J. Buyck, B.L.M. de Jonge,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates 
Cryptococcosis—the impact of delay to diagnosis
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Next-generation sequencing technologies and their application to the study and control of bacterial infections  J. Besser, H.A. Carleton, P. Gerner-Smidt,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Gut bacterial microbiota and obesity
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata.
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar  E. Tagliaferri, C. Tascini, A. Leonildi,
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
Dermatitis by Dermatophilus congolensis
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Phenotypic and molecular characterization of multidrug-resistant Salmonella enterica serovar Hadar in Greece, from 2007 to 2010  T. Papadopoulos, E. Petridou,
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum.
First isolation of Akkermansia muciniphila in a blood-culture sample
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Hepatitis C: global epidemiology and strategies for control
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts  R. Freeman 
Unveiling the molecular basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic of the Congo using whole genome sequencing 
Epidemiology of opportunistic infections in AIDS patients
Cutaneous myiasis—a stowaway from Central America
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar 
Elements of design: the knowledge on which we build
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital  L. Gibold, F. Robin, R.-N.
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
M. Aires-de-Sousa  Clinical Microbiology and Infection 
W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J
Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans  S.J. Vandecasteele, S. Seneca, J.
B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas 
S. David, M. Mentasti, J. Parkhill, V.J. Chalker 
Symposia and Oral Presentations
Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England  S. Thelwall,
Systematic review of antibiotic consumption in acute care hospitals
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Case–control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection  L.E.S. Bruijnesteijn.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with.
Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy  L. Boglione,
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model  Alasdair P. MacGowan,
Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle  A. Dalhoff,
Survival of rhinoviruses on human fingers
Virology: a scientific discipline facing new challenges
New oral cephalosporins in pediatric community-acquired infections
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
CMI editorial report, 2016 Clinical Microbiology and Infection
Molecular history of plague
The burden of chikungunya in the Pacific
Fernando Baquero, John F
S.A. Longworth, E.A. Blumberg, T.D. Barton, C. Vinnard 
CMI readers' survey Clinical Microbiology and Infection
Presentation transcript:

Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam–avibactam  A. Chauzy, J. Buyck, B.L.M. de Jonge, S. Marchand, N. Grégoire, W. Couet  Clinical Microbiology and Infection  Volume 25, Issue 4, Pages 515.e1-515.e4 (April 2019) DOI: 10.1016/j.cmi.2018.11.025 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Aztreonam MICs versus avibactam concentrations (mg/L) for 12 Enterobacteriaceae isolates. The circles represent the aztreonam MICs determined during one checkerboard experiment and the solid lines the individual aztreonam MICs predicted by the Emax model with baseline effect. Clinical Microbiology and Infection 2019 25, 515.e1-515.e4DOI: (10.1016/j.cmi.2018.11.025) Copyright © 2018 The Authors Terms and Conditions